Schmitt, S., Bertsch, U., & Goldschmidt, H. (2010). Experiences with bortezomib in multiple myeloma: From Phase II studies to daily practice. International journal of clinical pharmacology and therapeutics, 48(7), . https://doi.org/10.5414/CPP48494
Chicago Style (17th ed.) CitationSchmitt, Stefan, Uta Bertsch, and Hartmut Goldschmidt. "Experiences with Bortezomib in Multiple Myeloma: From Phase II Studies to Daily Practice." International Journal of Clinical Pharmacology and Therapeutics 48, no. 7 (2010). https://doi.org/10.5414/CPP48494.
MLA (9th ed.) CitationSchmitt, Stefan, et al. "Experiences with Bortezomib in Multiple Myeloma: From Phase II Studies to Daily Practice." International Journal of Clinical Pharmacology and Therapeutics, vol. 48, no. 7, 2010, https://doi.org/10.5414/CPP48494.